# Drug Manufacturers - General — Industry Hub

> Quantitative analysis from TrendMatrix. Data for informational use only — not investment advice.

Drug manufacturers develop and commercialize pharmaceutical products for treating human diseases and various medical conditions. Their stock performance is shaped by FDA approval success and timelines, patent protection and expiration risk, strong regulatory pricing pressures, and generic drug competition that steadily erodes blockbuster revenues and margins. TrendMatrix ranks 16 US-listed Drug Manufacturers - General stocks by 10-dimension quantitative score, refreshed every 5 minutes during market hours with a full reanalysis nightly.

- **Parent sector:** Healthcare
- **Stocks tracked:** 16 (primer N: 16)
- **Sentiment:** 3 bullish · 7 neutral · 6 bearish · avg score 5.49
- **Last updated:** 2026-04-25T16:28:11+00:00

## Ranked Stocks

| # | Symbol | Name | Verdict | Score | Price | Upside |
|---|---|---|---|---|---|---|
| 1 | [LLY](https://trendmatrix.com/stocks/LLY) | Eli Lilly and Company | STRONG_BUY_WAIT | 6.4 | $929.58 | +19.1% |
| 2 | [AMGN](https://trendmatrix.com/stocks/AMGN) | Amgen Inc. | STRONG_BUY_WAIT | 5.9 | $347.58 | +6.6% |
| 3 | [MRK](https://trendmatrix.com/stocks/MRK) | Merck & Company, Inc. | STRONG_BUY_WAIT | 5.4 | $111.58 | +6.7% |
| 4 | [GILD](https://trendmatrix.com/stocks/GILD) | Gilead Sciences, Inc. | HOLD_IF_HOLDING | 6.1 | $131.90 | +7.9% |
| 5 | [GSK](https://trendmatrix.com/stocks/GSK) | GSK plc | HOLD_IF_HOLDING | 6.1 | $52.45 | +11.2% |
| 6 | [BIIB](https://trendmatrix.com/stocks/BIIB) | Biogen Inc. | HOLD_IF_HOLDING | 5.8 | $191.41 | +0.0% |
| 7 | [AZN](https://trendmatrix.com/stocks/AZN) | AstraZeneca PLC | HOLD_IF_HOLDING | 5.6 | $189.04 | +3.0% |
| 8 | [BMY](https://trendmatrix.com/stocks/BMY) | Bristol-Myers Squibb Company | HOLD_IF_HOLDING | 5.4 | $60.22 | +7.3% |
| 9 | [SNY](https://trendmatrix.com/stocks/SNY) | Sanofi | HOLD_IF_HOLDING | 5.2 | $46.77 | +4.5% |
| 10 | [OGN](https://trendmatrix.com/stocks/OGN) | Organon & Co. | HOLD_IF_HOLDING | 5.0 | $13.32 | +23.1% |
| 11 | [GRFS](https://trendmatrix.com/stocks/GRFS) | Grifols, S.A. | SELL_IF_HOLDING | 5.6 | $8.18 | +15.2% |
| 12 | [ABBV](https://trendmatrix.com/stocks/ABBV) | AbbVie Inc. | SELL_IF_HOLDING | 5.4 | $214.09 | +6.9% |
| 13 | [PFE](https://trendmatrix.com/stocks/PFE) | Pfizer, Inc. | SELL_IF_HOLDING | 5.2 | $26.86 | +4.8% |
| 14 | [JNJ](https://trendmatrix.com/stocks/JNJ) | Johnson & Johnson | SELL_IF_HOLDING | 5.1 | $230.56 | +5.0% |
| 15 | [NVO](https://trendmatrix.com/stocks/NVO) | Novo Nordisk A/S | SELL_IF_HOLDING | 5.0 | $42.53 | -1.9% |
| 16 | [NVS](https://trendmatrix.com/stocks/NVS) | Novartis AG | SELL_IF_HOLDING | 4.6 | $148.01 | +3.7% |

## Recent 8-K Events (last 30 days)

- **AMGN** [Item 5.02] (2026-04-22): EVP David M. Reese retiring as CTO effective June 30, 2026. Responsibilities redistributed to EVPs Bradner, Gordon, and Griffith effective June 1, 2026. No successor named as CTO.

## Cross-Company Themes

- **Cardinal Health, Cencora, McKesson** — 1 companies (GILD)
- **HIV** — 1 companies (GILD)
- **Mounjaro and Zepbound** — 1 companies (LLY)
- **Puerto Rico** — 1 companies (AMGN)
- **TYSABRI and SPINRAZA** — 1 companies (BIIB)

## Related Industries

- [Health Information Services](https://trendmatrix.com/industries/health-information-services) — 13 stocks
- [Healthcare Plans](https://trendmatrix.com/industries/healthcare-plans) — 10 stocks
- [Medical Instruments & Supplies](https://trendmatrix.com/industries/medical-instruments-and-supplies) — 25 stocks
- [Diagnostics & Research](https://trendmatrix.com/industries/diagnostics-and-research) — 25 stocks
- [Medical Care Facilities](https://trendmatrix.com/industries/medical-care-facilities) — 27 stocks

## Canonical Links

- HTML: https://trendmatrix.com/industries/drug-manufacturers-general
- JSON: https://trendmatrix.com/api/industries/drug-manufacturers-general/rollup
- Markdown: https://trendmatrix.com/industries/drug-manufacturers-general.md